Back to Search
Start Over
Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
- Source :
- Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-4 (2022)
- Publication Year :
- 2022
- Publisher :
- BMC, 2022.
- Subjects :
- Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Subjects
Details
- Language :
- English
- ISSN :
- 17569966
- Volume :
- 41
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Journal of Experimental & Clinical Cancer Research
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.f0412950b142b39fc68d0d1d8f347c
- Document Type :
- article
- Full Text :
- https://doi.org/10.1186/s13046-022-02324-2